354 related articles for article (PubMed ID: 22939909)
1. Efficacy of marker vaccine candidate CP7_E2alf in piglets with maternally derived C-strain antibodies.
Rangelova D; Nielsen J; Strandbygaard B; Koenen F; Blome S; Uttenthal A
Vaccine; 2012 Oct; 30(45):6376-81. PubMed ID: 22939909
[TBL] [Abstract][Full Text] [Related]
2. Towards licensing of CP7_E2alf as marker vaccine against classical swine fever-Duration of immunity.
Gabriel C; Blome S; Urniza A; Juanola S; Koenen F; Beer M
Vaccine; 2012 Apr; 30(19):2928-36. PubMed ID: 22406108
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of CSF vaccine CP7_E2alf in piglets with maternally derived antibodies.
Eblé PL; Quak S; Geurts Y; Moonen-Leusen HW; Loeffen WL
Vet Microbiol; 2014 Nov; 174(1-2):27-38. PubMed ID: 25265929
[TBL] [Abstract][Full Text] [Related]
4. Protection against transplacental transmission of moderately virulent classical swine fever virus using live marker vaccine "CP7_E2alf".
Henke J; Carlson J; Zani L; Leidenberger S; Schwaiger T; Schlottau K; Teifke JP; Schröder C; Beer M; Blome S
Vaccine; 2018 Jul; 36(29):4181-4187. PubMed ID: 29895502
[TBL] [Abstract][Full Text] [Related]
5. CP7_E2alf: a safe and efficient marker vaccine strain for oral immunisation of wild boar against Classical swine fever virus (CSFV).
Koenig P; Lange E; Reimann I; Beer M
Vaccine; 2007 Apr; 25(17):3391-9. PubMed ID: 17257713
[TBL] [Abstract][Full Text] [Related]
6. An avirulent chimeric Pestivirus with altered cell tropism protects pigs against lethal infection with classical swine fever virus.
Reimann I; Depner K; Trapp S; Beer M
Virology; 2004 Apr; 322(1):143-57. PubMed ID: 15063124
[TBL] [Abstract][Full Text] [Related]
7. Reduced specificity of E
Meyer D; Loeffen W; Postel A; Fritsche S; Becher P
Transbound Emerg Dis; 2018 Apr; 65(2):e505-e508. PubMed ID: 29314759
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of marker vaccine candidate CP7_E2alf against challenge with classical swine fever virus isolates of different genotypes.
Blome S; Gabriel C; Schmeiser S; Meyer D; Meindl-Böhmer A; Koenen F; Beer M
Vet Microbiol; 2014 Feb; 169(1-2):8-17. PubMed ID: 24411658
[TBL] [Abstract][Full Text] [Related]
9. Cytokine and immunoglobulin isotype profiles during CP7_E2alf vaccination against a challenge with the highly virulent Koslov strain of classical swine fever virus.
Renson P; Le Dimna M; Gabriel C; Levai R; Blome S; Kulcsar G; Koenen F; Le Potier MF
Res Vet Sci; 2014 Apr; 96(2):389-95. PubMed ID: 24530018
[TBL] [Abstract][Full Text] [Related]
10. Two newly developed E(rns)-based ELISAs allow the differentiation of Classical Swine Fever virus-infected from marker-vaccinated animals and the discrimination of pestivirus antibodies.
Aebischer A; Müller M; Hofmann MA
Vet Microbiol; 2013 Jan; 161(3-4):274-85. PubMed ID: 22902189
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of maternally derived antibodies upon intramuscular vaccination against classical swine fever with Suvaxyn
Schröder C; Dräger C; Aebischer A; Dähnert L; Breidenstein C; Mamerow S; Leidenberger S; Beer M; Blome S
Vet Microbiol; 2016 Nov; 196():14-17. PubMed ID: 27939149
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Suvaxyn CSF Marker (CP7_E2alf) in the presence of pre-existing antibodies against Bovine viral diarrhea virus type 1.
Dräger C; Schröder C; König P; Tegtmeyer B; Beer M; Blome S
Vaccine; 2016 Sep; 34(39):4666-4671. PubMed ID: 27523739
[TBL] [Abstract][Full Text] [Related]
13. CP7_E2alf oral vaccination confers partial protection against early classical swine fever virus challenge and interferes with pathogeny-related cytokine responses.
Renson P; Le Dimna M; Keranflech A; Cariolet R; Koenen F; Le Potier MF
Vet Res; 2013 Feb; 44(1):9. PubMed ID: 23398967
[TBL] [Abstract][Full Text] [Related]
14. Modified live marker vaccine candidate CP7_E2alf provides early onset of protection against lethal challenge infection with classical swine fever virus after both intramuscular and oral immunization.
Leifer I; Lange E; Reimann I; Blome S; Juanola S; Duran JP; Beer M
Vaccine; 2009 Nov; 27(47):6522-9. PubMed ID: 19732859
[TBL] [Abstract][Full Text] [Related]
15. Pre-registration efficacy study of a novel marker vaccine against classical swine fever on Maternally Derived Antibody negative (MDA-) target animals.
Lévai R; Barna T; Fábián K; Blome S; Belák K; Bálint Á; Koenen F; Kulcsár G; Farsang A
Biologicals; 2015 Mar; 43(2):92-9. PubMed ID: 25637578
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of an Erns-based enzyme-linked immunosorbent assay to distinguish Classical swine fever virus-infected pigs from pigs vaccinated with CP7_E2alf.
Pannhorst K; Fröhlich A; Staubach C; Meyer D; Blome S; Becher P
J Vet Diagn Invest; 2015 Jul; 27(4):449-60. PubMed ID: 26179095
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of live marker vaccine candidates "CP7_E2alf" and "flc11" along with C-strain "Riems" after oral vaccination.
Blome S; Aebischer A; Lange E; Hofmann M; Leifer I; Loeffen W; Koenen F; Beer M
Vet Microbiol; 2012 Jul; 158(1-2):42-59. PubMed ID: 22397931
[TBL] [Abstract][Full Text] [Related]
18. First assessment of classical swine fever marker vaccine candidate CP7_E2alf for oral immunization of wild boar under field conditions.
Feliziani F; Blome S; Petrini S; Giammarioli M; Iscaro C; Severi G; Convito L; Pietschmann J; Beer M; De Mia GM
Vaccine; 2014 Apr; 32(18):2050-5. PubMed ID: 24565752
[TBL] [Abstract][Full Text] [Related]
19. Innocuousness and safety of classical swine fever marker vaccine candidate CP7_E2alf in non-target and target species.
König P; Blome S; Gabriel C; Reimann I; Beer M
Vaccine; 2011 Dec; 30(1):5-8. PubMed ID: 22064266
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a new chimeric marker vaccine candidate with a mutated antigenic E2-epitope.
Reimann I; Depner K; Utke K; Leifer I; Lange E; Beer M
Vet Microbiol; 2010 Apr; 142(1-2):45-50. PubMed ID: 19892497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
